PH24710A - Carbapenem compound in crystalline form, pharmaceutical composition containing said compound and process of preparation thereof - Google Patents

Carbapenem compound in crystalline form, pharmaceutical composition containing said compound and process of preparation thereof

Info

Publication number
PH24710A
PH24710A PH35599A PH35599A PH24710A PH 24710 A PH24710 A PH 24710A PH 35599 A PH35599 A PH 35599A PH 35599 A PH35599 A PH 35599A PH 24710 A PH24710 A PH 24710A
Authority
PH
Philippines
Prior art keywords
compound
preparation
pharmaceutical composition
composition containing
crystalline form
Prior art date
Application number
PH35599A
Other languages
English (en)
Inventor
Makoto Sunagawa
Yutaka Isobe
Yutaka Takeuchi
Yukio Ozaki
Tetsuo Noguchi
Haruki Matsumura
Original Assignee
Sumitomo Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Pharma filed Critical Sumitomo Pharma
Publication of PH24710A publication Critical patent/PH24710A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PH35599A 1986-07-30 1987-07-29 Carbapenem compound in crystalline form, pharmaceutical composition containing said compound and process of preparation thereof PH24710A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP17932186 1986-07-30
JP15776987 1987-06-26

Publications (1)

Publication Number Publication Date
PH24710A true PH24710A (en) 1990-10-01

Family

ID=26485103

Family Applications (1)

Application Number Title Priority Date Filing Date
PH35599A PH24710A (en) 1986-07-30 1987-07-29 Carbapenem compound in crystalline form, pharmaceutical composition containing said compound and process of preparation thereof

Country Status (20)

Country Link
US (1) US4888344A (fr)
EP (1) EP0256377B1 (fr)
JP (1) JP2665767B2 (fr)
AR (1) AR243189A1 (fr)
AU (1) AU596857B2 (fr)
CA (1) CA1322371C (fr)
DE (1) DE3781980T2 (fr)
DK (1) DK172666B1 (fr)
ES (1) ES2052524T3 (fr)
FI (1) FI88037C (fr)
GR (1) GR3006254T3 (fr)
HK (1) HK169595A (fr)
HU (1) HU199473B (fr)
IE (1) IE60588B1 (fr)
IL (1) IL83372A (fr)
LU (1) LU88635I2 (fr)
MX (1) MX173359B (fr)
NO (2) NO165543C (fr)
NZ (1) NZ221224A (fr)
PH (1) PH24710A (fr)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1283906C (fr) * 1983-05-09 1991-05-07 Makoto Sunagawa COMPOSE DE .beta.-LACTAM ET PROCEDE DE PRODUCTION
KR880006244A (ko) * 1986-11-24 1988-07-22 후지사와 도모 기찌 로 3-피롤리디닐티오-1-아자바이스클로[3.2.0]햅트2-엔-2-카르복실산 화합물 및 이의 제조방법
EP0406863B1 (fr) * 1989-07-06 1995-05-24 Banyu Pharmaceutical Co., Ltd. Dérivés cycliques de l'amidinylthiocarbapénème
DE69013131T2 (de) * 1989-12-29 1995-05-24 Banyu Pharma Co Ltd 2-(2-Cyclopropylpyrrolidin-4-ylthio)carbapenemderivate.
TW264475B (fr) * 1991-09-20 1995-12-01 Takeda Pharm Industry Co Ltd
JP2696807B2 (ja) * 1992-08-06 1998-01-14 田辺製薬株式会社 カルバペネム誘導体の製法
GB9503717D0 (en) * 1995-02-24 1995-04-12 Smithkline Beecham Plc Novel compounds
FR2735474B1 (fr) * 1995-06-13 1997-08-08 Roussel Uclaf Chlorhydrate de zilpaterol sous une forme cristallisee particuliere, son procede de preparation et les produits intermediaires mis en oeuvre
TR199901887T2 (xx) * 1997-02-07 1999-12-21 Kyoto Pharmaceutical Industries, Ltd. Karbapenem bile�i�i, bu bile�i�in kullan�m� ve bu bile�ik i�in ara bile�ik.
SK16382000A3 (sk) 1998-05-01 2001-05-10 Kyoto Pharmaceutical Industries, Ltd. Karbapénové deriváty, ich vyžitie a ich medziproduktové zlúčeniny
JP4130078B2 (ja) * 1999-06-03 2008-08-06 エーザイ・アール・アンド・ディー・マネジメント株式会社 カルバペネム誘導体結晶と注射製剤
US7041660B2 (en) 1999-07-06 2006-05-09 Sankyo Company, Limited Crystalline 1-methylcarbapenem derivatives
TWI250160B (en) * 1999-07-06 2006-03-01 Sankyo Co Crystalline 1-methylcarbapenem compound
WO2001085171A1 (fr) * 2000-05-12 2001-11-15 Novalar Pharmaceuticals, Inc. Methodes et kits d'anesthesie locale
JP5079190B2 (ja) * 2001-04-27 2012-11-21 大日本住友製薬株式会社 アゼチジノン誘導体およびその製造方法
MXPA03010607A (es) * 2001-05-21 2004-04-02 Kyoto Pharma Ind Compuesto de carbapenem.
KR100451672B1 (ko) * 2001-06-05 2004-10-08 한미약품 주식회사 결정성 세프디니르 산부가염, 이의 제조방법 및 이를이용한 세프디니르의 제조방법
EP1426376A4 (fr) * 2001-08-13 2004-12-22 Eisai Co Ltd Procede de preparation d'antibiotiques a base de carbapenem
CN100387599C (zh) * 2001-09-26 2008-05-14 麦克公司 用于生产碳青霉烯化合物的方法
EP1442038A4 (fr) * 2001-09-26 2005-01-05 Merck & Co Inc Formes cristallines d'antibiotiques a base de carbapeneme et procedes de preparation
ITMI20012364A1 (it) * 2001-11-09 2003-05-09 Antibioticos Spa Processo di sintesi della cefixima via alchil-o arilsolfonati
AU2003217676B2 (en) 2002-02-22 2009-06-11 Takeda Pharmaceutical Company Limited Active agent delivery systems and methods for protecting and administering active agents
US20030236306A1 (en) * 2002-06-20 2003-12-25 Chen Andrew X. Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof
US7229630B2 (en) * 2002-06-20 2007-06-12 Novalar Pharmaceuticals, Inc. Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof
EP1950563A3 (fr) 2002-09-11 2008-08-06 Michio Ishibashi Méthode de criblage une substance pour la promotion-régénération des macrophages
EP1776365B1 (fr) * 2004-06-02 2011-08-03 Sandoz Ag Intermediaire de meropenem sous forme cristalline
WO2006035300A2 (fr) * 2004-09-30 2006-04-06 Ranbaxy Laboratories Limited Procede de preparation de meropenem
JP4547245B2 (ja) * 2004-12-16 2010-09-22 株式会社パーマケム・アジア ペリンドプリルエルブミンのｉ型結晶、及びその製造方法
US20110039943A1 (en) * 2005-03-14 2011-02-17 Robert Alonso Methods for treating skin disorders with topical nitrogen mustard compositions
US7872050B2 (en) * 2005-03-14 2011-01-18 Yaupon Therapeutics Inc. Stabilized compositions of volatile alkylating agents and methods of using thereof
US8501818B2 (en) * 2005-03-14 2013-08-06 Ceptaris Therapeutics, Inc. Stabilized compositions of alkylating agents and methods of using same
US20070197781A1 (en) * 2005-07-29 2007-08-23 Neera Tewari Processes for the preparation of carbapenems
EP1926732B1 (fr) 2005-09-05 2013-11-06 Ranbaxy Laboratories Limited Composes de carpapenem: operation amelioree de fabrication
WO2007031858A2 (fr) * 2005-09-15 2007-03-22 Orchid Chemicals And Pharmaceuticals Limited Procede ameliore de preparation d'un antibiotique beta-lactame
CN100497338C (zh) * 2006-01-05 2009-06-10 上海医药工业研究院 4－甲基－7－氧－1－氮杂双环[3.2.0]庚－2－烯－2－羧酸类衍生物的制备方法
KR100781821B1 (ko) * 2006-02-16 2007-12-03 문순구 카르바페넴계 화합물의 제조방법
WO2007111328A1 (fr) * 2006-03-28 2007-10-04 Kaneka Corporation Procédé amélioré de production d'un composé de carbapenem
KR20090007572A (ko) * 2006-04-28 2009-01-19 카네카 코포레이션 카르바페넴 항생 물질 중간체의 개량된 정석 방법
WO2009075309A1 (fr) * 2007-12-12 2009-06-18 Dainippon Sumitomo Pharma Co., Ltd. Composition de préparation
US20090216010A1 (en) * 2008-02-22 2009-08-27 Wei-Hong Tseng Crystalline carbapenem compound and produced method thereof
EP2098525A1 (fr) 2008-02-26 2009-09-09 Savior Lifetec Corporation Composé de carbapenem cristallin et son procédé de production
CN102036557A (zh) * 2008-03-27 2011-04-27 耀鹏医疗有限公司 烷基化剂的稳定组合物及其使用方法
US8097719B2 (en) * 2008-07-15 2012-01-17 Genesen Labs Meropenem intermediate in novel crystalline form and a method of manufacture of meropenem
AU2009277936B2 (en) * 2008-07-30 2014-11-27 Sun Pharmaceutical Industries Limited Process for the preparation of carbapenem compounds
RU2490270C2 (ru) 2009-03-13 2013-08-20 Даевунг Фармасьютикал Ко., Лтд. Улучшенный способ получения меропенема с применением цинкового порошка
WO2011048583A1 (fr) 2009-10-23 2011-04-28 Ranbaxy Laboratories Limited Procédé pour la préparation de composés de carbapénème
WO2011141847A1 (fr) * 2010-05-10 2011-11-17 Orchid Chemicals And Pharmaceuticals Limited Procédé amélioré pour la préparation de méropénem
AU2011319478A1 (en) 2010-10-22 2013-05-23 Sun Pharmaceutical Industries Limited A process for the preparation of pure meropenem trihydrate
CN101962383A (zh) * 2010-11-12 2011-02-02 上海巴迪生物医药科技有限公司 一种美罗培南的合成方法
WO2012081033A2 (fr) * 2010-12-06 2012-06-21 Sequent Scientific Limited Procédé de préparation d'imipénem
CN102532140B (zh) * 2010-12-21 2015-03-11 北大方正集团有限公司 一种美罗培南三水合物的制备方法
CN102250096B (zh) * 2011-09-05 2016-04-06 江西华邦药业有限公司 一种美罗培南的制备方法
CN103570718B (zh) * 2012-07-31 2016-06-29 深圳市海滨制药有限公司 一种美罗培南原料药、其制备方法及包含其的药物组合物
CN103570720B (zh) * 2012-07-31 2016-02-10 新乡海滨药业有限公司 一种美罗培南原料药、其制备方法及包含其的药物组合物
CN103570719B (zh) * 2012-07-31 2016-03-02 深圳市海滨制药有限公司 一种美罗培南原料药、其制备方法及包含其的药物组合物
KR101331762B1 (ko) 2012-12-28 2013-11-20 주식회사 대웅제약 메로페넴의 삼수화물의 제조방법
CN103044429B (zh) * 2013-01-28 2015-04-01 苏州二叶制药有限公司 一种美罗培南的制备方法
AU2014212275B2 (en) 2013-02-01 2018-09-06 Ocuphire Pharma, Inc. Methods and compositions for daily ophthalmic administration of phentolamine to improve visual performance
CA2899339C (fr) 2013-02-01 2021-07-06 Ocularis Pharma, Llc Solutions ophtalmiques aqueuses de phentolamine et utilisations medicales associees
KR102144777B1 (ko) 2013-06-19 2020-08-18 제이더블유중외제약 주식회사 결정형 메로페넴 삼수화물의 제조방법
CN110922405A (zh) * 2014-03-27 2020-03-27 庄信万丰股份有限公司 制备碳青霉烯抗生素的方法
CN113164452A (zh) 2018-10-26 2021-07-23 奥库菲尔制药股份有限公司 治疗老花眼、散瞳和其他眼部疾病的方法和组合物
CN115368310A (zh) 2021-05-18 2022-11-22 奥库菲尔医药公司 合成甲磺酸酚妥拉明的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK153486C (da) * 1978-07-03 1988-11-28 Merck & Co Inc Analogifremgangsmaade til fremstilling af krystallinsk n-formimidoyl-thienamycin-monohydrat
EP0113101A1 (fr) * 1982-12-30 1984-07-11 Merck & Co. Inc. Esters d'acides 6-(1-hydroxyéthyl)-2-SR8-1-méthyl-1-carbadéthiapén-2-ème-3-carboxyliques
JPS60104088A (ja) * 1983-11-11 1985-06-08 Sumitomo Chem Co Ltd 新規なβ−ラクタム化合物およびその製造法
CA1283906C (fr) * 1983-05-09 1991-05-07 Makoto Sunagawa COMPOSE DE .beta.-LACTAM ET PROCEDE DE PRODUCTION
US4748238A (en) * 1984-03-14 1988-05-31 Merck & Co., Inc. Crystalline 1R,5S,6S,8R-1-methyl-2-(N,N-dimethylcarbamimidoylmethylthio)-6-(1-hydroxyethyl)-1-carbapen-2-em-3-carboxylic acid
US4713451A (en) * 1984-04-09 1987-12-15 Merck & Co., Inc. Crystalline dimethyliminothienamycin
US4761408A (en) * 1984-11-02 1988-08-02 Ciba-Geigy Corporation Crystalline aminomethyl compound
NZ214691A (en) * 1984-12-27 1988-08-30 Sumitomo Pharma The preparation of carbapenem derivatives and beta-lactam intermediates
US4788282A (en) * 1985-06-07 1988-11-29 Bristol-Myers Company Deprotection of allylic esters and ethers

Also Published As

Publication number Publication date
ES2052524T3 (es) 1994-07-16
IE871959L (en) 1988-01-30
NZ221224A (en) 1989-10-27
IL83372A0 (en) 1987-12-31
DK399087D0 (da) 1987-07-30
HU199473B (en) 1990-02-28
DK172666B1 (da) 1999-05-10
NO873205D0 (no) 1987-07-30
GR3006254T3 (fr) 1993-06-21
AU596857B2 (en) 1990-05-17
DK399087A (da) 1988-01-31
EP0256377A1 (fr) 1988-02-24
HUT44553A (en) 1988-03-28
AU7619687A (en) 1988-03-03
MX173359B (es) 1994-02-23
DE3781980D1 (de) 1992-11-05
US4888344A (en) 1989-12-19
NO165543C (no) 1991-02-27
LU88635I2 (fr) 1995-12-01
JP2665767B2 (ja) 1997-10-22
AR243189A1 (es) 1993-07-30
FI873299A0 (fi) 1987-07-29
HK169595A (en) 1995-11-10
CA1322371C (fr) 1993-09-21
IE60588B1 (en) 1994-07-27
NO1997013I1 (no) 1997-10-17
FI88037C (fi) 1993-03-25
NO165543B (no) 1990-11-19
FI873299A (fi) 1988-01-31
JPS6434986A (en) 1989-02-06
EP0256377B1 (fr) 1992-09-30
IL83372A (en) 1992-05-25
MX7534A (es) 1993-10-01
FI88037B (fi) 1992-12-15
DE3781980T2 (de) 1993-02-18
NO873205L (no) 1988-02-01

Similar Documents

Publication Publication Date Title
PH24710A (en) Carbapenem compound in crystalline form, pharmaceutical composition containing said compound and process of preparation thereof
PT84936A (en) Process for the preparation of tetrahydronaphthaline and indanederivatives and of pharmaceutical compositions containing the same
HUT46710A (en) Process for producing peptode derivatives and pharmaceutical compositions containing them as active components
HUT43825A (en) Process for producing quinolon-carboxylic acid derivatives and pharmaceutical compositions containing them
HUT47274A (en) Process for producing terciary hydroxy-alkyl-xantines and pharmaceutical compositions containing them as active components
PT81007A (en) Process for the preparation of analgesic 1,2-benzisothiazol-3-ylpiperazine derivatives and of pharmaceutical compositions containing the same
HUT45252A (en) Process for producing imidazo-pyridine derivatives and pharmaceutical compositions containing them as active components
AU6558186A (en) N-benzoyl urea compounds, antitumorous compositions containing them, and process for their preparation
IL79672A (en) Process for the preparation of crystalline torasemide of pure modification i,and pharmaceutical compositions containing it
PT85762A (en) Process for the preparation of new cephem compounds and pharmaceutical compositions containing same
HUT47278A (en) Process for producing pyrrolo-benzimidazols and pharmaceutical compositions containing them
EP0289170A3 (en) Azabicyclic compounds, process for their preparation and pharmaceutical compositions containing them
PT86365A (en) Process for the preparation of pyridazodiazepine derivatives and of pharmaceutical compositions containing the same
ZA874626B (en) Azabicyclic compounds,process and intermediates for their preparation and pharmaceutical compositions containing them
PT84358A (en) Process for the preparation of naphthothiazepinones and of pharmaceutical compositions containing the same
EP0251453A3 (en) Substituted amino-dihydrooxazoles, -thiazoles and -imidazoles, process for their preparation and pharmaceutical compositions containing them
HUT43820A (en) Process for producing n-(-2-((-2-hydroxy-phenyl-)(-phenyl-)-methylene-aminosquare )-ethyl-)-acetamide derivatives and pharmaceutical compositions containing them
PT84923A (en) Process for the preparation of 1-(hydroxystyrul)-5h-2,3-benzodiapezine derivatives and pharmaceutical compositions containing the same
HUT46930A (en) Process for producing aminoglycoside-steroides and pharmaceutical compositions containing them as active components
PT85513A (en) Process for the preparation of pyrimidine derivatives and of pharmaceutical compositions containing the same
PT85522A (en) Process for the preparation of pyrimidine derivatives and of pharmaceutical compositions containing the same
HUT46030A (en) Process for producing citostatic antracyclin-glycoside derivatives and pharmaceutical compositions containing them
HUT44527A (en) Process for producing new alkylene-diamine derivatives and pharmaceutical compositions containing them
IL84791A0 (en) Substituted aminopropionamides,process for their preparation and pharmaceutical compositions containing them
PT86297A (en) Process for preparing aryloxybenzeneacetic acid derivatives and of pharmaceutical compositions containing the same